Genetic variants in the 53BP1 gene and skin cancer risk

Journal of Investigative Dermatology

Volumn 130, Issue 12, 2010, Pages 2850-2853

  He, Chunyan ^a,b   Nan, Hongmei ^c,d   Qureshi, Abrar A ^d   Han, Jiali ^c,d  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

53BP1 GENE; CANCER RISK; CONTROLLED STUDY; GENE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CANCER;

EID: 78149464923     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.227     Document Type: Letter

References (14)

1. Cui R, Widlund HR, Feige E et al. (2007) Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 128: 853-64
2. DiTullio RA Jr, Mochan TA, Venere M et al. (2002) 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nat Cell Biol 4:998-1002
3. Frank B, Hemminki K, Bermejo JL et al. (2005) TP53-binding protein variants and breast cancer risk: a case-control study. Breast Cancer Res 7:R502-5
4. Han J, Colditz GA, Liu JS et al. (2005) Genetic variation in XPD, sun exposure, and risk of skin cancer. Cancer Epidemiol Biomarkers Prev 14:1539-44
5. Huyen Y, Zgheib O, Ditullio RA Jr et al. (2004) Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature 432:406-11
6. Iwabuchi K, Li B, Massa HF et al. (1998) Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2. J Biol Chem 273: 26061-8
7. Izagirre N, Garcia I, Junquera C et al. (2006) A scan for signatures of positive selection in candidate loci for skin pigmentation in humans. Mol Biol Evol 23:1697-706
8. Joo WS, Jeffrey PD, Cantor SB et al. (2002) Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Genes Dev 16:583-93
9. Ma H, Hu Z, Zhai X et al. (2006) Joint effects of single nucleotide polymorphisms in P53BP1 and p53 on breast cancer risk in a Chinese population. Carcinogenesis 27:766-71
10. Nan H, Qureshi AA, Hunter DJ et al. (2009) A functional SNP in the MDM2 promoter, pigmentary phenotypes, and risk of skin cancer. Cancer Causes Control 20: 171-9
11. Rapakko K, Heikkinen K, Karppinen SM et al. (2007) Germline alterations in the 53BP1 gene in breast and ovarian cancer families. Cancer Lett 245:337-40
12. Rappold I, Iwabuchi K, Date T et al. (2001) Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J Cell Biol 153: 613-20
13. Wang B, Matsuoka S, Carpenter PB et al. (2002) 53BP1, a mediator of the DNA damage checkpoint. Science 298:1435-8
14. Ward IM, Minn K, van Deursen J et al. (2003) p53 binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice. Mol Cell Biol 23:2556-63